ATLANTA, February 4, 2011 — A new American Cancer Society report says cancers associated with lifestyles and behaviors related to economic development, including lung, breast, and colorectal cancers, will continue to rise in developing countries if…
ATLANTA — February 1, 2011 — While the overall death rate for cancer continues to drop among African Americans, the group continues to have higher death rates and shorter survival of any racial and ethnic group in the U.S. for most cancers. The f…
Lung cancer is the leading cause of cancer deaths worldwide, and the prognosis is generally poor, even if surgery is successful. Furthermore, the incidence of one type of lung cancer, adenocarcinoma, has been increasing in recent years. A better und…
Surveying patients who were screened for colorectal cancer, investigators at the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis found that most prefer “virtual” colonoscopy to traditional screening, but most had positive appraisals of both. Patients didn’t, however, like the bowel preparation prior to either screening test.
A national study indicates that patients who have had previous colorectal cancer and take 325 milligrams of aspirin each day — the equivalent of one adult aspirin — may lower the risk of developing new colon polyps by 35 percent. Polyps appear to be precursors to most colorectal cancers. The double-blind study randomly assigned half of the 635 patients who previously had colorectal cancer to an aspirin treatment group. The other half received a placebo or sugar pill. The results of the study will be published in the March 6, 2003, issue of the New England Journal of Medicine.
Treating precancerous breast cells with chemopreventive agents like tamoxifen limits the development of breast cancer in genetically predisposed women, according to a new study. Precancerous breast cells may also provide an effective mechanism for screening new and current chemopreventive agents, the study found.